Leading diabetes groups release recommendations on incretin therapy and pancreatic disease

The American Diabetes Association (ADA), the European Association for the Study of Diabetes (EASD) and the International Diabetes Federation (IDF) have released new recommendations for Clinicians and People with Diabetes Concerning the Use of Incretin Therapy and Pancreatic Disease.

The full recommendation can be accessed here. For more information, please contact info@idf.org